Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05306743

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Led by Observational and Pragmatic Research Institute · Updated on 2023-10-12

126

Participants Needed

3

Research Sites

218 weeks

Total Duration

On this page

Sponsors

O

Observational and Pragmatic Research Institute

Lead Sponsor

T

The DARTNet Institute (DI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

CONDITIONS

Official Title

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Primary care teams must function as a single unit for randomization with low risk of contamination between members.
  • Primary care teams must have a sufficient number of patients meeting modifiable high-risk COPD criteria.
  • Primary care teams must be willing to be randomized to either receive the CONQUEST program immediately or continue usual care until later.
Not Eligible

You will not qualify if you...

  • Primary care teams planning to change electronic health record software or practice ownership during the trial outcome evaluation period.
  • Primary care teams engaged in active research or COPD-related quality improvement programs that could interfere with the CONQUEST program implementation.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

University of Colorado

Denver, Colorado, United States, 80309

Actively Recruiting

2

Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

3

MetroHealth

Cleveland, Ohio, United States, 44109

Actively Recruiting

Loading map...

Research Team

D

David Price, FRCGP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here